Organigram Global Inc. logo OGI - Organigram Global Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 2
HOLD 2
SELL 1
STRONG
SELL 0

Stock News

Organigram: Record Harvests Are The Root Of Market Share Erosion

Organigram: Record Harvests Are The Root Of Market Share Erosion

Organigram's disappointing Q2 earnings could be a direct result of its record harvests overwhelming downstream capacity. Expected Sanity contribution to full-year revenue and adjusted EBITDA guidance suggests that organic growth may turn negative in the second half of FY 2026. Persistent out-of-spec exports point to a severe bottleneck in drying capacity, where overcrowded drying rooms are fostering microbial growth and driving inconsistent drying.

May 20, 2026 03:07 AM • seekingalpha.com
Organigram Reports Second Quarter Fiscal 2026 Results

Organigram Reports Second Quarter Fiscal 2026 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the second quarter ended March 31, 2026 (“Q2 Fiscal 2026” or "Q2"). Q2 FISCAL 2026 HIGHLIGHTS Gross Revenue: $93.3 million (-9% year-over-year). Net Revenue: $59.8 million (-9% year-over-year). International Revenue: $6.1 million (0% year-over-year). Adjusted EBITDA2: $0.9 million (-82% year-over-year).

May 12, 2026 02:00 AM • businesswire.com
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026

Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2026 ended March 31, 2026, on Tuesday, May 12, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, May 12, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use t.

May 06, 2026 02:00 AM • businesswire.com
Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities

Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities

TORONTO & BERLIN--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) and Sanity Group GmbH (“Sanity” or “Sanity Group”) jointly announced the successful closing of Organigram's previously announced acquisition (the “Acquisition”) of Sanity Group, pursuant to the terms of a share purchase agreement dated February 18, 2026 (the “Share Purchase Agreement”). In connection with closing of the Acquisition, a wholly owned subsidiary of the Company acquire.

Apr 15, 2026 08:03 AM • businesswire.com
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the “Transaction”) of Sanity Group GmbH (“Sanity Group”) and the related private placement financing (the “Private Placement”) with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco (“.

Mar 30, 2026 04:30 PM • businesswire.com
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annu.

Mar 23, 2026 02:00 AM • businesswire.com
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on March 30, 2026. The Circular is available under Organigram's profile on SEDAR+ at ww.

Mar 10, 2026 02:00 AM • businesswire.com
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity

Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1 is pleased to announce the launch of SHRED Shotz, a compact, single-serve 65ml cannabis beverage powered by FAST™, Organigram's fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset2. This launch reflects Organigram's focus on differentiated innovation while leveraging the scale of SHRED, one of the Company's best-.

Mar 05, 2026 01:00 AM • businesswire.com
3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio

3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio

Marijuana stocks, even with their volatile behavior, still offer diverse investment opportunities. Not every sector or company deals directly with the plant, so investors see this as an opportunity to capitalize. Now, even with that said, MSO and companies that work directly with the plant tend to capture more market share. Also, they are usually the first to see a run in trading when the time comes.

Feb 27, 2026 08:50 AM • marijuanastocks.com
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia

Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) today announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cannabis vape and pastille products in Australia. Australia has become one of the world's most dynamic medical cannabis markets, with increasing approvals for access and prescribers utilising a broader range of dosage forms1. While flower remains a core category, alternatives such as vapes and pastille.

Feb 24, 2026 01:00 AM • businesswire.com
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading global cannabis company, today announced that it has entered into a subscription agreement (the “Subscription Agreement”) with BT DE Investments Inc. ( “BAT”), a wholly-owned subsidiary of British American Tobacco p.l.c. (LSE: BATs and NYSE: BTI), in connection with its previously announced proposed acquisition (the “Acquisition”) of Sanity Group GmbH (“Sanity” or “Sanity Group”.

Feb 19, 2026 01:00 AM • businesswire.com
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company

Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into a definitive agreement (the “Purchase Agreement”) to acquire (the “Acquisition”) all the issued and outstanding shares of Sanity Group GmbH (“Sanity” or “Sanity Group”) not currently owned by Organigram. Upon closing of the Acquisition, Organigram will pay shareholders of Sanity (collectively, the “Ve.

Feb 18, 2026 01:00 AM • businesswire.com
3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026

3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026

What is it about the cannabis industry that keeps investors searching for top marijuana stocks to buy? Cannabis started as one of the first waves of peace, love, and rebellion towards many cultural injustices. Today, those same principles are the foundation in spirit. But the evolution of legal cannabis changed the culture forever. In 2026, significant changes have occurred and continue to happen. We have a battle for who will take over, will it be corporate cannabis or will the true cul;tiovaots be able to take back the industry.

Feb 13, 2026 06:37 AM • marijuanastocks.com
Organigram Global Is Now A Strong Buy

Organigram Global Is Now A Strong Buy

Organigram is upgraded to Strong Buy despite Q1 revenue and EBITDA missing estimates, citing long-term value and strategic positioning. OGI trades at a low 7.8x CY26 projected EBITDA and 1.1x tangible book value, reflecting limited downside for a debt-free, legally operating company. Strategic partnerships with British American Tobacco and international expansion targets—especially in Germany, Australia, and Israel—support growth prospects.

Feb 11, 2026 11:35 AM • seekingalpha.com

Price Targets

No price target news available.